Piha-Paul S - Search Results

1

Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors.

Tsimberidou AM, Vo HH, Subbiah V, Janku F, Piha-Paul S, Yilmaz B, Gong J, Naqvi MF, Tu SM, Campbell M, Meric-Bernstam F, Naing A. Tsimberidou AM, et al. Oncologist. 2021 Jul;26(7):558-e1098. doi: 10.1002/onco.13682. Epub 2021 Feb 12. Oncologist. 2021. PMID: 33491277 Free PMC article. Clinical Trial.

2

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.

Janku F, Tsimberidou AM, Garrido-Laguna I, Wang X, Luthra R, Hong DS, Naing A, Falchook GS, Moroney JW, Piha-Paul SA, Wheler JJ, Moulder SL, Fu S, Kurzrock R. Janku F, et al. Mol Cancer Ther. 2011 Mar;10(3):558-65. doi: 10.1158/1535-7163.MCT-10-0994. Epub 2011 Jan 7. Mol Cancer Ther. 2011. PMID: 21216929 Free PMC article.

3

Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience.

Wheler J, Tsimberidou AM, Hong D, Naing A, Falchook G, Piha-Paul S, Fu S, Moulder S, Stephen B, Wen S, Kurzrock R. Wheler J, et al. Clin Cancer Res. 2012 May 15;18(10):2922-9. doi: 10.1158/1078-0432.CCR-11-2217. Epub 2012 Mar 27. Clin Cancer Res. 2012. PMID: 22452943 Free PMC article.

4

Advance care planning in patients with cancer referred to a phase I clinical trials program: the MD Anderson Cancer Center experience.

Fu S, Barber FD, Naing A, Wheler J, Hong D, Falchook G, Piha-Paul S, Tsimberidou A, Howard A, Kurzrock R. Fu S, et al. J Clin Oncol. 2012 Aug 10;30(23):2891-6. doi: 10.1200/JCO.2011.38.0758. Epub 2012 Jul 9. J Clin Oncol. 2012. PMID: 22778314 Clinical Trial.

5

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative.

Tsimberidou AM, Iskander NG, Hong DS, Wheler JJ, Falchook GS, Fu S, Piha-Paul S, Naing A, Janku F, Luthra R, Ye Y, Wen S, Berry D, Kurzrock R. Tsimberidou AM, et al. Clin Cancer Res. 2012 Nov 15;18(22):6373-83. doi: 10.1158/1078-0432.CCR-12-1627. Epub 2012 Sep 10. Clin Cancer Res. 2012. PMID: 22966018 Free PMC article.

6

PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials.

Janku F, Wheler JJ, Naing A, Falchook GS, Hong DS, Stepanek VM, Fu S, Piha-Paul SA, Lee JJ, Luthra R, Tsimberidou AM, Kurzrock R. Janku F, et al. Cancer Res. 2013 Jan 1;73(1):276-84. doi: 10.1158/0008-5472.CAN-12-1726. Epub 2012 Oct 12. Cancer Res. 2013. PMID: 23066039 Free PMC article.

7

Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy.

Wheler JJ, Falchook GS, Tsimberidou AM, Hong DS, Naing A, Piha-Paul SA, Chen SS, Fu S, Stephen B, Fok JY, Janku F, Kurzrock R. Wheler JJ, et al. Ann Oncol. 2013 Mar;24(3):838-42. doi: 10.1093/annonc/mds524. Epub 2012 Nov 8. Ann Oncol. 2013. PMID: 23139256 Free PMC article.

8

Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liver.

Tsimberidou AM, Leick MB, Lim J, Fu S, Wheler J, Piha-Paul SA, Hong D, Falchook GS, Naing A, Subbiah IM, Fortier A, Avritscher R, Kurzrock R. Tsimberidou AM, et al. Cancer Chemother Pharmacol. 2013 Feb;71(2):389-97. doi: 10.1007/s00280-012-2014-8. Epub 2012 Nov 11. Cancer Chemother Pharmacol. 2013. PMID: 23143207 Clinical Trial.

9

A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.

Hong DS, Choe JH, Naing A, Wheler JJ, Falchook GS, Piha-Paul S, Moulder SL, George GC, Choe JM, Strauss LC, Gallick GE, Kurzrock R. Hong DS, et al. Invest New Drugs. 2013 Aug;31(4):918-26. doi: 10.1007/s10637-012-9898-3. Epub 2012 Nov 20. Invest New Drugs. 2013. PMID: 23179336 Free PMC article. Clinical Trial.

10

PIK3CA mutations in advanced cancers: characteristics and outcomes.

Janku F, Wheler JJ, Naing A, Stepanek VM, Falchook GS, Fu S, Garrido-Laguna I, Tsimberidou AM, Piha-Paul SA, Moulder SL, Lee JJ, Luthra R, Hong DS, Kurzrock R. Janku F, et al. Oncotarget. 2012 Dec;3(12):1566-75. doi: 10.18632/oncotarget.716. Oncotarget. 2012. PMID: 23248156 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page